109 related articles for article (PubMed ID: 1531540)
1. Isolation, characterization, and immunological detection of neutrophil-activating peptide 2: a proteolytic degradation product of platelet basic protein.
Holt JC; Yan ZQ; Lu WQ; Stewart GJ; Niewiarowski S
Proc Soc Exp Biol Med; 1992 Feb; 199(2):171-7. PubMed ID: 1531540
[TBL] [Abstract][Full Text] [Related]
2. Effects of the neutrophil-activating peptide NAP-2, platelet basic protein, connective tissue-activating peptide III and platelet factor 4 on human neutrophils.
Walz A; Dewald B; von Tscharner V; Baggiolini M
J Exp Med; 1989 Nov; 170(5):1745-50. PubMed ID: 2681518
[TBL] [Abstract][Full Text] [Related]
3. Structural requirements of platelet chemokines for neutrophil activation.
Yan Z; Zhang J; Holt JC; Stewart GJ; Niewiarowski S; Poncz M
Blood; 1994 Oct; 84(7):2329-39. PubMed ID: 7919350
[TBL] [Abstract][Full Text] [Related]
4. CXC chemokines connective tissue activating peptide-III and neutrophil activating peptide-2 are heparin/heparan sulfate-degrading enzymes.
Hoogewerf AJ; Leone JW; Reardon IM; Howe WJ; Asa D; Heinrikson RL; Ledbetter SR
J Biol Chem; 1995 Feb; 270(7):3268-77. PubMed ID: 7852412
[TBL] [Abstract][Full Text] [Related]
5. Neutrophil-activating intercrine secreted by porcine platelets is active without proteolytic processing.
Yan Z; Holt JC; Stewart GJ; Niewiarowski S
Am J Physiol; 1993 Nov; 265(5 Pt 1):C1396-404. PubMed ID: 8238487
[TBL] [Abstract][Full Text] [Related]
6. Formation of neutrophil-activating peptide 2 from platelet-derived connective-tissue-activating peptide III by different tissue proteinases.
Car BD; Baggiolini M; Walz A
Biochem J; 1991 May; 275 ( Pt 3)(Pt 3):581-4. PubMed ID: 2039437
[TBL] [Abstract][Full Text] [Related]
7. Thrombin-activated human platelets release two NAP-2 variants that stimulate polymorphonuclear leukocytes.
Piccardoni P; Evangelista V; Piccoli A; de Gaetano G; Walz A; Cerletti C
Thromb Haemost; 1996 Nov; 76(5):780-5. PubMed ID: 8950790
[TBL] [Abstract][Full Text] [Related]
8. Purification, crystallization and preliminary X-ray diffraction analysis of recombinant human neutrophil-activating peptide 2 (rhNAP-2).
Kungl AJ; Machius M; Huber R; Schwer C; Lam C; Aschauer H; Ehn G; Lindley IJ; Auer M
FEBS Lett; 1994 Jun; 347(2-3):300-3. PubMed ID: 8034022
[TBL] [Abstract][Full Text] [Related]
9. A novel cleavage product of beta-thromboglobulin formed in cultures of stimulated mononuclear cells activates human neutrophils.
Walz A; Baggiolini M
Biochem Biophys Res Commun; 1989 Mar; 159(3):969-75. PubMed ID: 2522778
[TBL] [Abstract][Full Text] [Related]
10. Conversion of low-affinity platelet factor 4 to beta-thromboglobulin by plasmin and trypsin.
Holt JC; Niewiarowski S
Biochim Biophys Acta; 1980 Oct; 632(2):284-9. PubMed ID: 6158345
[TBL] [Abstract][Full Text] [Related]
11. Novel C-terminally truncated isoforms of the CXC chemokine beta-thromboglobulin and their impact on neutrophil functions.
Ehlert JE; Gerdes J; Flad HD; Brandt E
J Immunol; 1998 Nov; 161(9):4975-82. PubMed ID: 9794434
[TBL] [Abstract][Full Text] [Related]
12. The beta-thromboglobulins and platelet factor 4: blood platelet-derived CXC chemokines with divergent roles in early neutrophil regulation.
Brandt E; Petersen F; Ludwig A; Ehlert JE; Bock L; Flad HD
J Leukoc Biol; 2000 Apr; 67(4):471-8. PubMed ID: 10770278
[TBL] [Abstract][Full Text] [Related]
13. Down-regulation of neutrophil functions by the ELR(+) CXC chemokine platelet basic protein.
Ehlert JE; Ludwig A; Grimm TA; Lindner B; Flad HD; Brandt E
Blood; 2000 Nov; 96(9):2965-72. PubMed ID: 11049972
[TBL] [Abstract][Full Text] [Related]
14. The amino-terminal residues in the crystal structure of connective tissue activating peptide-III (des10) block the ELR chemotactic sequence.
Malkowski MG; Lazar JB; Johnson PH; Edwards BF
J Mol Biol; 1997 Feb; 266(2):367-80. PubMed ID: 9047370
[TBL] [Abstract][Full Text] [Related]
15. Generation of the neutrophil-activating peptide NAP-2 from platelet basic protein or connective tissue-activating peptide III through monocyte proteases.
Walz A; Baggiolini M
J Exp Med; 1990 Feb; 171(2):449-54. PubMed ID: 2406364
[TBL] [Abstract][Full Text] [Related]
16. Connective tissue-activating peptide III desensitizes chemokine receptors on neutrophils. Requirement for proteolytic formation of the neutrophil-activating peptide 2.
Härter L; Petersen F; Flad HD; Brandt E
J Immunol; 1994 Dec; 153(12):5698-708. PubMed ID: 7989767
[TBL] [Abstract][Full Text] [Related]
17. Characterization of human platelet basic protein, a precursor form of low-affinity platelet factor 4 and beta-thromboglobulin.
Holt JC; Harris ME; Holt AM; Lange E; Henschen A; Niewiarowski S
Biochemistry; 1986 Apr; 25(8):1988-96. PubMed ID: 2423119
[TBL] [Abstract][Full Text] [Related]
18. The crystal structure of recombinant human neutrophil-activating peptide-2 (M6L) at 1.9-A resolution.
Malkowski MG; Wu JY; Lazar JB; Johnson PH; Edwards BF
J Biol Chem; 1995 Mar; 270(13):7077-87. PubMed ID: 7706245
[TBL] [Abstract][Full Text] [Related]
19. Generation of the neutrophil-activating peptide-2 by cathepsin G and cathepsin G-treated human platelets.
Cohen AB; Stevens MD; Miller EJ; Atkinson MA; Mullenbach G
Am J Physiol; 1992 Aug; 263(2 Pt 1):L249-56. PubMed ID: 1387511
[TBL] [Abstract][Full Text] [Related]
20. Chemical synthesis, purification, and characterization of two inflammatory proteins, neutrophil activating peptide 1 (interleukin-8) and neutrophil activating peptide.
Clark-Lewis I; Moser B; Walz A; Baggiolini M; Scott GJ; Aebersold R
Biochemistry; 1991 Mar; 30(12):3128-35. PubMed ID: 2007144
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
